{"id":"W2991540591","doi":"10.1016/j.jaci.2019.11.025","title":"Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial","year":2019,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":357,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"AbbVie","keywords":"Medicine; Placebo; Randomized controlled trial; Atopic dermatitis; Eczema Area and Severity Index; Adverse effect; Clinical endpoint; Internal medicine; Surgery; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003679164,0.001442031,0.003667899,0.0003722596,0.0004382638,0.001213145,0.0008613848,0.001839757,0.005836833],"category_scores_gemma":[0.003127384,0.0005888756,0.002663137,0.0004344872,0.000831224,0.001040019,0.0004973536,0.001881537,0.0007146008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006209509,"about_ca_system_score_gemma":0.0009147744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004896928,"about_ca_topic_score_gemma":0.001435049,"domain_scores_codex":[0.9985968,0.000744496,0.0001466071,0.0002210713,0.0001359443,0.0001550325],"domain_scores_gemma":[0.9984182,0.0004362606,0.000510899,0.0001440827,0.000161063,0.0003294841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9784206,0.003148751,0.000877226,0.001381995,0.002381937,0.00005277683,0.00004121054,0.0001550035,0.001834663,0.00004047691,0.0006540091,0.01101126],"study_design_scores_gemma":[0.9760216,0.01969671,0.002222094,0.00006878284,0.001175223,0.00003240014,0.0000154625,0.0001265357,0.0001620754,0.00004982582,0.0004193526,0.000009914515],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9657489,0.02100422,0.0008759516,0.001058121,0.001041248,0.00614107,0.00163548,0.000147263,0.002347745],"genre_scores_gemma":[0.978415,0.008734737,0.001484552,0.001506151,0.0007123541,0.005214245,0.001328638,0.00002468744,0.002579708],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005836833,"threshold_uncertainty_score":0.01952618,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01379008931329156,"score_gpt":0.2865810797549208,"score_spread":0.2727909904416292,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}